Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-23-087738
Filing Date
2023-03-31
Accepted
2023-03-31 13:56:27
Documents
48
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d460879d10k.htm   iXBRL 10-K 891927
2 EX-31.1 d460879dex311.htm EX-31.1 10576
3 EX-31.2 d460879dex312.htm EX-31.2 10576
4 EX-32.1 d460879dex321.htm EX-32.1 4286
5 EX-32.2 d460879dex322.htm EX-32.2 4291
  Complete submission text file 0001193125-23-087738.txt   3828538

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bios-20221231.xsd EX-101.SCH 38615
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bios-20221231_cal.xml EX-101.CAL 18449
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bios-20221231_def.xml EX-101.DEF 203586
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bios-20221231_lab.xml EX-101.LAB 258313
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bios-20221231_pre.xml EX-101.PRE 242891
42 EXTRACTED XBRL INSTANCE DOCUMENT d460879d10k_htm.xml XML 368512
Mailing Address 260 MADISON AVENUE, SUITE 800 NEW YORK NY 10016
Business Address 260 MADISON AVENUE, SUITE 800 NEW YORK NY 10016 2122874092
BioPlus Acquisition Corp. (Filer) CIK: 0001856653 (see all company filings)

EIN.: 981583272 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41116 | Film No.: 23786515
SIC: 6770 Blank Checks